Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-23-130042)

Filing Details

Accession Number:: 0001104659-23-130042
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-28 16:02:09
Reporting Period:: 2023-12-26

Accepted Time:: 2023-12-28 16:02:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1211583	Fennec Pharmaceuticals Inc.	FENC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1185945	A Chris Rallis	C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2023-12-26	1,390	$10.90	44,788	No	4	S	Direct
Common Shares	Acquisiton	2023-12-26	3,144	$1.59	46,178	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Options	Common Shares	Disposition	2023-12-26	3,144	$1.59	3,144	$1.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
184,168	2014-01-24	2024-01-24	No	4	M	Direct

Footnotes

Shares sold to satisfy tax obligation on option exercise.
Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024.
Represents options granted on January 24, 2014, with a strike price of $1.59 and expiration date of January 24, 2024.